Medtronic Plc (MDT) Q3 2025 (USD): Adj. EPS 1.36 (exp. 1.34), Revenue 9.00bln (exp. 8.91bln), sees FY Adj. EPS between 5.62-5.66 (exp. 5.65)

Medtronic's Q3 results exceeded expectations on both adjusted EPS and revenue, indicating stronger-than-anticipated operational performance.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Iran reportedly floats new ideas in Nuclear talks, but not the proposal that interests Trump, according to WSJ; Iranian officials have floated pausing uranium enrichment, but fall short of a pledge to stop enrichment

Genuine Parts Company (GPC) Q4 2025 (USD): Adj. EPS 1.55 (exp. 1.82), Revenue 6.01bln (exp. 6.06bln); lifts quarterly dividend c. 3% and confirms plans to separate automotive and industrial businesses into two Cos.

Medtronic Plc (MDT) Q3 2025 (USD): Adj. EPS 1.36 (exp. 1.34), Revenue 9.00bln (exp. 8.91bln), sees FY Adj. EPS between 5.62-5.66 (exp. 5.65)

Qualcomm (QCOM) says the UK lawsuit alleging its chip royalties caused smartphone owners to overpay has been withdrawn

General Mills (GIS) expects FY26 organic net sales -1.5 to -2%, FY adj. operating profit and FY adj. EPS -16 to -20%

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

Additionally, the guidance for FY adjusted EPS is in line with consensus, reflecting confidence in ongoing growth amid the healthcare landscape. This solid performance could bolster investor sentiment toward Medtronic and the healthcare sector, particularly if market participants view these results as a confirmation of a positive trend in earnings.

Related headlines

The whole workspace, free to try.

Try it free